RxDoctor Payments Data

Shawna Steffan

Physician Assistant · Conroe, TXNPI 1134401482

Payments from drug & device makers

$1,924in general payments, 2019–2025

Across 115 payments — averaging $16.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$231
  • Novo Nordisk$226
  • Lilly USA, LLC$224
  • Boehringer Ingelheim$169
  • AstraZeneca$159
  • AbbVie$118
  • plus $798 from 20 others

What the payments were for

  • Food & beverage$1,924100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,924 in reported general payments places this provider in the 75th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$15,383
Lantus SolostarInsulin Glargine,hum.Rec.Anlog14$1,293
Atorvastatin Calcium72$900
Gabapentin35$396
Metformin Hcl25$347
Duloxetine Hcl16$332
Losartan Potassium22$328
Propranolol Hcl12$324
Potassium Chloride14$274
Albuterol Sulfate HfaAlbuterol Sulfate12$268
Levothyroxine Sodium29$262
Metoprolol Succinate23$243
Rosuvastatin Calcium20$233
Pantoprazole Sodium25$224
Omeprazole17$217

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$226$15,38315 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Conroe

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →